Hecht Beth
SEC CIK 1652410 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks | 1.13M | — | $1.52M | 22 | 2021-10-05 | 2026-09-01 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-01 18:21 | 2026-09-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $8.49 | -16.7K | 1.13M | -1% | -$141.4K |
| T | 2026-08-04 17:16 | 2026-08-03 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $8.01 | -16.7K | 1.14M | -1% | -$133.6K |
| T | 2026-07-02 16:38 | 2026-07-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $8.03 | -16.7K | 1.16M | -1% | -$133.9K |
| T | 2026-06-02 18:05 | 2026-06-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $6.06 | -16.7K | 1.18M | -1% | -$101.0K |
| T | 2026-05-01 17:50 | 2026-05-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $6.23 | -16.7K | 1.19M | -1% | -$103.8K |
| T | 2026-04-03 17:45 | 2026-04-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $5.99 | -16.7K | 1.21M | -1% | -$99.9K |
| M | 2026-03-04 | 2026-03-02 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $6.24 | -16.7K | 1.23M | -1% | -$104.1K |
| D | 2026-02-02 | 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $7.45 | -16.7K | 1.24M | -1% | -$124.2K |
| DM | 2026-02-02 | 2026-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | F - Tax | $7.36 | -169.6K | 1.33M | -11% | -$1.25M |
| D | 2026-02-02 | 2026-01-30 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | A - Grant | $0.00 | +121.3K | 1.43M | +9% | $0 |
| 2026-01-05 | 2026-01-02 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $7.43 | -16.7K | 1.31M | -1% | -$123.8K | |
| 2025-12-02 | 2025-12-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $7.01 | -16.7K | 1.32M | -1% | -$116.8K | |
| 2025-11-13 | 2025-11-11 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $7.40 | -16.7K | 1.34M | -1% | -$123.3K | |
| 2025-03-21 | 2025-03-20 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale | $5.43 | -40.0K | 1.35M | -3% | -$217.2K | |
| DM | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | F - Tax | $3.56 | -144.3K | 1.31M | -10% | -$513.7K |
| D | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | A - Grant | $0.00 | +185.0K | 1.39M | +15% | $0 |
| 2025-01-07 | 2025-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | F - Tax | $3.61 | -32.0K | 1.35M | -2% | -$115.7K | |
| M | 2024-08-09 | 2022-01-29+ | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | F - Tax | $1.97 | -178.0K | 1.54M | -10% | -$350.6K |
| 2024-01-31 | 2024-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | A - Grant | $0.00 | +750.0K | 1.55M | +93% | $0 | |
| 2023-02-01 | 2023-01-31 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | A - Grant | $0.00 | +350.0K | 797.8K | +78% | $0 | |
| 2022-01-05 | 2022-01-03 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | A - Grant | $0.00 | +225.0K | 436.8K | +106% | $0 | |
| DM | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | A - Grant | — | +206.4K | 206.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations